Literature DB >> 357381

Cefoxitin sodium: a clinical and pharmacological study.

D S Reeves, A J Bint, H A Holt, P J Stocks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 357381     DOI: 10.1093/jac/4.suppl_b.155

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

2.  The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.

Authors:  D S Reeves; D W Bullock; M J Bywater; H A Holt; L O White; D P Thornhill
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 3.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

5.  Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.

Authors:  P H Vlasses; A M Holbrook; J J Schrogie; J D Rogers; R K Ferguson; W B Abrams
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

Review 6.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.